The STEP-ONE program (Supportive Training and Essential Preparation for Optimal Nursing Education) - what have we done and what will we do in the STEP-TWO edition?

Abstract

Abstract Introduction The STEP-ONE program was a significant initiative designed to enhance the skills and knowledge of nurses specializing in heart failure care in Central and Eastern Europe, and the Baltic countries (CEE-BA). Purpose Its importance lies in addressing the crucial role of nurses in heart failure management, an area often overlooked in these regions. By training nurses to provide optimal, integrated care, the program aims to improve patient outcomes and reduce hospitalizations. The number of nurses who participated in the program is not specified, but its impact is likely substantial in advancing heart failure care. Continuing the program as the STEP-TWO edition is planned to be updated of nurses and patients materials according to ESC HF 2023 guidelines6, taking into account the profile of the patient with HFrEF, HFmREF, HFimEF, HFpEF and taking into account the implementation of pilot projects: (1a) Assessment of HFpEF risk7 and recommendations for medical staff regarding further diagnostics; (1b) Analysis of recommended therapies according to guidelines; (2) Pilot training Program center Poland centers- CEE-BA; (3) Pilot research programs - 1a and 1/b in 2-3 centers (fig.1). All of the activities undertaken in the program are intended to improve care for heart failure patients and can be seen as a model solution for providing qualified personnel in the European countries. Conclusions The STEP ONE educational program was developed with the participation of the medical community, especially nurses caring for HF patients. Educational materials for nurses and patients, as well as an educational program, were prepared and implemented in Poland and the region of CEE-BA. During the second phase, an updated materials with the 2023 guidelines on HF will be prepared. A pilot study will evaluate the impact of educating HF nurses on patient risk assessment of HFPEF and on identifying patients who do not have optimal therapy according to GDMT. Optimization of the HF patient pathway at the pilotage centers of the program and collaboration between HF nurses and cardiologists will be sought. Moreover, the STEP-TWO program will include preparing educational materials focused and dedicated not only on patients but also on caregivers.